Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 805-561-2 | CAS number: 350601-49-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 28 December 2012 to 25 January 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted to GLP in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- up-and-down procedure
- Limit test:
- yes
Test material
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Appearance: Variable coloured powder
- Storage conditions of the test material: Ambient
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 9 to 11 weeks
- Weight at study initiation: 170.1 to 192.2 g. The body weight variation of animals was minimal and did not exceed ± 20 per cent of the previously dosed animals.
- Fasting period before study: Yes. Animals were fasted overnight prior to dosing (16 to 18 hours). Access to water was not interrupted and the animals were fed immediately after dosing.
- Housing: Rats were housed individually in standard polysulfone plastic solid-bottom cages (Size: approximately 425 mm long x 266 mm deep x 175 mm high), with stainless steel top grills having facilities for pelleted food and drinking water. Steam sterilised clean corn cob bedding was used and changed along with the cage twice weekly. The rats were provided with huts as environmental enrichment in each cage during the experimental period.
- Diet (e.g. ad libitum): Standard rat and mouse pelleted maintenance diet was provided ad libitum
- Water (e.g. ad libitum): Deep bore-well water passed through activated charcoal filter and exposed to UV rays in a water filter-cum-purifier was provided to animals ad libitum in polycarbonate bottles with stainless steel sipper tubes.
- Acclimation period: Five to fourteen days under standard laboratory conditions.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 23 °C
- Humidity (%): 65 to 66 % (relative)
- Air changes (per hr): 12 to 15 air changes/hour
- Photoperiod (hrs dark / hrs light): 12 hours of light and 12 hours of dark
IN-LIFE DATES: From: 28 December 2012 To: 25 January 2013
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: Milli-Q water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/mL as a suspension.
- Justification for choice of vehicle: The test material formed a visibly homogenous suspension in the chosen vehicle.
MAXIMUM DOSE VOLUME APPLIED: The volume administered was 10 mL/kg bodyweight.
DOSAGE PREPARATION: 2 g of the test material was mixed by adding small quantities of Milli-Q water until a final volume of 10 mL was reached. Homogeneity of the test material in the vehicle was maintained during treatment by constant stirring and mixing with a glass rod. Preparations were made prior (within 1 hour) to dosing.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: The limit value was selected as the starting dose. - Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5 females per dose
- Control animals:
- no
- Details on study design:
- - Dosing schedule: Single animals were dosed in sequence. Each subsequent animal was dosed only after assessing the toxicity of the test material to the previously dosed animal.
- Duration of observation period following administration: 14 days following test material administration.
- Frequency of observations and weighing: The animals were observed five times on test day 1 (day of administration), at 30 minutes, 1, 2, 3 and 4 hours after dose administration and once daily during days 2 to 15. Individual body weights of animals were recorded on test day 1 (pre-administration), day 8 (7 days post administration) and day 15 (14 days post administration).
- Necropsy of survivors performed: Yes. All animals were necropsied at the end of the 14-day observation period; animals were sacrificed by exsanguination under isoflurane anaesthesia. External surfaces of the body, all orifices, tissues and organs of the thoracic and abdominal cavities of all animals were examined for gross pathological changes. The stomach was opened, the contents rinsed / removed, and the mucosal surface was examined for signs of irritation, erosions and ulcers. All necropsy observations were recorded.
Results and discussion
- Preliminary study:
- The limit test at 2000 mg/kg was initiated with one female rat. The first animal survived and there were no clinical signs of toxicity or mortality; hence four additional female rats were tested sequentially at the same dose.
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There was no mortality. All animals exposed to the limit dose survived.
- Clinical signs:
- other: There were no clinical signs of toxicity in any animal.
- Gross pathology:
- There were no abnormalities detected at necropsy.
Any other information on results incl. tables
Table 1: Body Weight and Body Weight Changes
Step |
Rat Number |
Body weight (g) |
||||
Initial (Day 1) |
Day 8 |
Weight change (Day 8 -Initial) |
Day 15 |
Weight change (Day 15 -Initial) |
||
1 |
Rm1431 |
170.1 |
198.6 |
28.5 |
207.8 |
37.7 |
2 |
Rm1432 |
182.5 |
203.6 |
21.1 |
218.9 |
36.4 |
3 |
Rm1433 |
184.1 |
209.6 |
25.5 |
218.2 |
34.1 |
4 |
Rm1434 |
184.2 |
200.8 |
16.6 |
219.6 |
35.4 |
5 |
Rm1435 |
192.2 |
209.8 |
17.6 |
222.1 |
29.9 |
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study, the acute oral LD50 was >2000 mg/kg bodyweight in female Wistar strain rats and the test material requires no classification in accordance with EU criteria.
- Executive summary:
The acute oral toxicity potential of the test material to female Wistar strain rats was assessed in accordance with the standardised guidelines OECD 425 and US EPA OPPTS 870.1100 under GLP conditions.
The study was initiated with a limit test at 2000 mg/kg with one female rat. The test material was mixed in Milli-Q water and administered as a single oral dose via gavage to fasted rats. The first animal survived, hence four additional animals were tested sequentially with the same dose.
Rats were observed for 14 days post treatment. All animals were sacrificed as scheduled on study Day 15 and subjected to gross necropsy.
There were no clinical signs of toxicity and none of the animals died. All the animals gained body weight during the 14-day observation period. There were no gross abnormalities detected in any of the rats at necropsy.
Under the conditions of this study, the acute oral LD50 was >2000 mg/kg bodyweight and the test material requires no classification in accordance with EU criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Aunque la ECHA ofrece una gran cantidad de material en su idioma, una parte de esta página está solo disponible en inglés. Más información sobre la política de multilingüismo de la ECHA.
Bienvenido a la página web de la ECHA. Este sitio no es plenamente compatible con Explorer 7 (y versiones anteriores). Por favor, actualice su Internet Explorer a una versión más reciente.
Esta web utiliza cookies para mejorar su experiencia de navegación en nuestros sitios web.
Más información sobre el uso de cookies.